Ambrose Kristen sold VRTX
February 17, 2026 · Form 4 insider transaction
Ambrose Kristen sold 1,557 shares of Vertex Pharmaceuticals Incorporated at $489.46 per share, a transaction worth $762.1K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Disposed (sell-side)
Shares
1,557
Price
$489.46
Total value
$762.1K
InsiderAmbrose Kristen
Role—
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateFebruary 17, 2026
Filing dateFebruary 19, 2026
Shares owned after8,388
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
Transaction made pursuant to Ms. Ambrose's company approved trading plan under Rule 10b5-1, which was entered into on 08/08/2025.